Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
Advances in Therapy - United States
doi 10.1007/s12325-020-01277-2
Full Text
Open PDFAbstract
Available in full text
Date
March 12, 2020
Authors
Publisher
Springer Science and Business Media LLC